Peter Attia· MD
even if that's the case they would not be as good as what Peter would predict after all the tests that you run your biological AG that's what I want to get to
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
even if that's the case they would not be as good as what Peter would predict after all the tests that you run your biological AG that's what I want to get to
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
what Peter would predict after all the tests that you run your biological age that's what I want to get to yes and I think what you are actually doing is looking at other biomarkers that have a long-term clinical history that you're using to come up with a surrogate but really is reflecting largely biological age maybe not completely